Hendrik Weitkamp, M.D.

Assistant Professor of Pediatrics, Division of Neonatology

Member

Hendrik Weitkamp, M.D.

Contact Info

Phone
(615) 322-3476

Website
http://www.ncbi.nlm.nih.gov/m/pubmed/

Email
hendrik.weitkamp@vanderbilt.edu

Address
1125 MRB IV

Overview of Interests

Jörn-Hendrik Weitkamp, M.D., is currently Assistant Professor of Pediatrics in the Division of Neonatology at Vanderbilt University Medical Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville, Tennessee.

Dr. Weitkamp received his medical degree from the University of Ulm in Germany and completed his residency in Pediatrics at the University Hospital of Bonn in Germany and Vanderbilt University Medical Center. He subsequently completed fellowships and is board-certified in Pediatric Infectious Diseases and Perinatal-Neonatal Medicine.

Dr. Weitkamp’s laboratory investigates the development, phenotype, function, and metabolism of peripheral blood and intestinal mucosa T cell populations isolated from preterm infants and studies their role in important outcomes such as necrotizing enterocolitis (NEC) and brain injury. Specifically he investigates the effects of fetal immune activation on priming of T helper cells, FOXP3+ T regulatory cells and innate lymphoid cells. In collaboration with Dr. Sar Peters at the VKC, Dr. Weitkamp studies immune cell changes associated with Rett and MECP2 deletion syndrome.

Dr. Weitkamp’s laboratory also uses 16S rRNA technology to interrogate the fetal and neonatal microbiome and how it informs the developing immune system. Dr. Weitkamp’s training in infectious diseases, immunology and neonatal/perinatal medicine allows him to analyze the entire sequence of maternal infection/environmental exposures, its influence on the fetal microbiome and developing immune system followed by preterm birth and prematurity-associated infectious and inflammatory complications.

BioSketch

View Biographical Sketch (.pdf)